Navigator-assisted hypofractionation (NAVAH) phase I clinical trial of breast cancer patients: Implications for assessing personal versus familial financial toxicity via the Comprehensive Score for Financial Toxicity-Functional Assessment of Chronic Illness Therapy (COST-FACIT) survey instrument.
Year: 2025
Type: article
Source: Journal of Clinical Oncology
Language: English
Subfield: Economics and Econometrics
Domain: Social Sciences
Open Access status: closed
OpenAlex ID: W4410811875
